-+ 0.00%
-+ 0.00%
-+ 0.00%

BELITE BIO SHARES FALL 10.6% PREMARKET AS FDA EXTENDS REVIEW OF EYE DISEASE DRUG

Reuters·11/20/2026 13:14:05

Please log in to view news